{(S)-4-[(R)-2-((R)-1-Hydroxy-1-hydroxycarbamoyl-ethyl)-5-phenyl-pentanoylamino]-4-methylcarbamoyl-butyl}-carbamic acid tert-butyl ester

InChIKey	`SJPBXYWXFIQQJH-XHNVNVPESA-N`
Compound Name	{(S)-4-[(R)-2-((R)-1-Hydroxy-1-hydroxycarbamoyl-ethyl)-5-phenyl-pentanoylamino]-4-methylcarbamoyl-butyl}-carbamic acid tert-butyl ester
Canonical SMILES	`CNC(=O)[C@H](CCCNC(=O)OC(C)(C)C)NC(=O)[C@H](CCCc1ccccc1)[C@@](C)(O)C(=O)NO`
Clinical Status	Clinical Multi-Target
Targets (Human+Pathogen)	5
Pfam Stratification	Cross-Family
Avg pChEMBL	8.09
Source	ChEMBL;BindingDB;TTD_MultiTarget

2D Structure

Activity Profile

Target	Gene	Organism	Category	Pfam	pChEMBL	Type	Source
P14780	MMP9	Homo sapiens	Human	PF00040 PF00045 PF00413	8.7	Ki	ChEMBL;BindingDB
P08254	MMP3	Homo sapiens	Human	PF00045 PF00413 PF01471	7.9	Ki	ChEMBL;BindingDB
P03956	MMP1	Homo sapiens	Human	PF00045 PF00413 PF01471	7.8	Ki	ChEMBL;BindingDB
Q9ULZ9	MMP17	Homo sapiens	Human	PF00045 PF00413 PF01471	7.8	pIC50	TTD_MultiTarget
P18843	nadE	Escherichia coli (strain K12)	Pathogen	PF02540	8.2	pIC50	TTD_MultiTarget